Endodermal sinus tumor (
EST), also known as
yolk sac tumor (
YST), is a member of the
germ cell tumor group of
cancers. It is the most common testicular tumor in children under 3, and is also known as
infantile embryonal carcinoma. This age group has a very good prognosis. In contrast to the pure form typical of infants, adult endodermal sinus tumors are often found in combination with other kinds of germ cell tumor, particularly
teratoma and
embryonal carcinoma. While pure teratoma is usually
benign, endodermal sinus tumor is
malignant.
Diagnosis
The
histology of EST is variable, but usually includes malignant endodermal cells. These cells secrete
alpha-fetoprotein (AFP), which can be detected in tumor tissue,
serum,
cerebrospinal fluid,
urine and, in the rare case of fetal EST, in
amniotic fluid. When there is incongruence between
biopsy and AFP test results for EST, the result indicating presence of EST dictates treatment. This is because EST often occurs as small "malignant foci" within a larger tumor, usually
teratoma, and biopsy is a sampling method; biopsy of the tumor may reveal only teratoma, whereas elevated AFP reveals that EST is also present. GATA-4, a
transcription factor, also may be useful in the diagnosis of EST.
Schiller-Duval bodies on histology are
pathognomonic.
Diagnosis of EST in pregnant women and in infants is complicated by the normal extremely high levels of AFP in those two groups. Tumor surveillance by monitoring AFP requires accurate correction for gestational age in pregnant women, and age in infants. In pregnant women, this can be achieved simply by testing maternal serum AFP rather than tumor marker AFP. In infants, the tumor marker test is used, but must be interpreted using a reference table or graph of normal AFP in infants.
Treatment
Most treatments involve some combination of
surgery and
chemotherapy.
Before modern chemotherapy, this type of neoplasm was highly lethal, but the prognosis has significantly improved since.
90% survival rate when treated effectively.
References